The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension
Abstract
SPECIAL MEDICAL EDITORIALSFrom bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertensionErnesto L. Schiffrin, and Rhian M. TouyzErnesto L. Schiffrin, and Rhian M. TouyzPublished Online:01 Aug 2004https://doi.org/10.1152/ajpheart.00262.2004MoreSectionsPDF (268 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations resistance arteries are vessels of ∼100–300 μm in lumen diameter that are an important site of resistance to blood flow. Small artery-dependent increased peripheral resistance may participate in development and complications of hypertension. The degree of remodeling of small arteries has prognostic significance over a 10-yr period, with worse prognosis for hypertensive subjects with greater remodeling. In almost all hypertensive subjects, a reduction in lumen and an increase in the media-to-lumen ratio are found, without increase in its media cross section, as a result of rearrangement of smooth muscle cells and increased collagen and fibronectin. Approximately 60% of hypertensive patients exhibit endothelial dysfunction already in stage 1 hypertension. Study of human vascular smooth muscle cells and of vessels from experimental animals has demonstrated that ANG II, aldosterone, and endothelin exert remodeling effects in large measure by activation of NADPH oxidase, and to lesser degree by stimulating xanthine oxidase and mitochondrial reactive oxygen species generation. Stimulation of angiotensin type 1 (AT1) receptors (AT1R) leads to increased reactive oxygen species in part via activation of nonreceptor tyrosine kinases such as c-src, and of PKC and phospholipase D, and thereby contributes to endothelial dysfunction by inactivating nitric oxide (NO). Treatment of hypertensive patients with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers, but not β-blockers, corrects small artery structure and endothelial dysfunction, which may favorably affect outcome in the long term, beyond the 3–5 yr of randomized clinical trials during which most antihypertensives affect outcome similarly as long as blood pressure is well controlled.RESISTANCE ARTERIES IN HYPERTENSION: FROM CLINIC TO LABORATORYA major objective of translational research from bench to bedside is to test in humans novel therapeutic modalities developed through experimentation. However, because our understanding of many human diseases, such as hypertension, is still very limited, there is a critical need for bedside to bench research. We and other researchers have demonstrated that in human hypertension, resistance arteries undergo remodeling and altered reactivity. What remains uncertain, however, is how these processes occur and whether they are primary causative events or secondary adaptive phenomena. To answer some of these questions, it is imperative to extend bedside observations and findings to the bench, where molecular and cellular processes underlying vascular changes in hypertension can be studied in isolated vessels and cells in in vitro conditions. Ideally, one would like to examine cells directly involved in the pathological process under investigation. In hypertension, this includes vascular smooth muscle cells in resistance arteries. However, because of ethical and practical constraints, this is not always possible, and most studies investigating subcellular processes in hypertension are conducted, in large part, in cells from animal models, where hypertension is spontaneous or induced experimentally. When human cells are examined, they are usually derived from large arteries and veins obtained during surgery, from postmortem specimens, or from immortalized cell lines. Because these conditions do not control for blood pressure status and other variables of subjects from whom the cells are derived, it is inordinately difficult to extrapolate findings from such cell models to what may be happening in vascular cells during the development of hypertension. Because circulating blood cells are easily accessible from humans, many investigators have studied cellular events and signaling cascades in platelets, erythrocytes, and leukocytes as markers of events in vascular cells. However, this model is suboptimal because circulating cells are devoid of a supporting extracellular matrix and adventitia and have very different morphological and functional phenotypes compared with vascular smooth muscle cells.Over the past 10 yr, we successfully developed a system for the study of isolated vessels and vascular smooth muscle cells derived from human small arteries obtained from gluteal biopsies of subcutaneous tissue. This unique approach provides multiple benefits. First, small arteries and vascular cells derived from these are obtained from healthy individuals and well-characterized hypertensive patients, with or without treatment. Second, the vascular smooth muscle cells are derived from resistance arteries, which
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · cited 1×
“Impaired endothelial function may result from reduced generation of NO due to reduced expression/abundance of endothelial NO synthase (eNOS) or decreased activation of eNOS, and increases in oxidative stress that reduce the bioavailability of NO through conversion to peroxynitrate (14, 100, 185).”
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,585
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
(2000) · PubMed · Cited by 2,095
Close Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033 · cited 1×
“We have shown that endothelial function of small arteries from gluteal subcutaneous biopsies correlates closely with endothelium-dependent brachial artery flow-mediated dilatation (114), which in turn correlates with coronary vasomotion (5).”
BackgroundPhysiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768 · cited 1×
“Whether there is amplification of vasoconstrictor responses by the structural or mechanical reduction of lumen diameter according to the law of Laplace (47, 48, 80, 199, 200) is controversial (75).”
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,655
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 1,406
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130 · cited 1×
“Numerous meta-analyses of randomized clinical trials (9, 154), and the recent Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (54) and Second Australian National Blood Pressure studies (198) demonstrate that most agents reduce cardiovascular events largely to a similar degree as long as blo…”
BackgroundReactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,004
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Self-citationCardiovascular protection and blood pressure reduction: a meta-analysis
Staessen, J. A., Wang, J.-G., & Thijs, L. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06411-x · Cited by 944
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Self-citationStructure and function of small arteries
Mulvany, M. J., & Aalkjaer, C. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.921 · Cited by 913
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Lüscher, T. F., & Vanhoutte, P. M. (1986) · Hypertension · doi:10.1161/01.hyp.8.4.344 · Cited by 878
Blood Pressure and Inflammation in Apparently Healthy Men
Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 716
Ushio-Fukai, M., Alexander, R. W., Akers, M., & Griendling, K. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15022 · Cited by 650
Gibbons, G. H., Pratt, R. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115881 · Cited by 645
Small artery structure in hypertension. Dual processes of remodeling and growth.
Heagerty, A. M., Aalkjaer, C., Bund, S. J., Korsgaard, N., & Mulvany, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.21.4.391 · Cited by 645
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 630
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 616
Self-citationTouyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Self-citationVascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586 · cited 1×
“It is unclear whether angiotensin II, endothelin-1, or aldosterone, agents that participate in the pathophysiology of hypertension and that induce inflammation in the heart, the vasculature, and the kidney (12, 82, 129, 171, 193) or blood pressure elevation by itself, through effects on adhesion molecules, chemokines,…”
BackgroundRedox signaling and the MAP kinase pathways
Torres, M., & Forman, H. J. (2003) · BioFactors · doi:10.1002/biof.5520170128 · Cited by 580
Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells
Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., & Griendling, K. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000112024.13727.2c · Cited by 573
p22phox mRNA Expression and NADPH Oxidase Activity Are Increased in Aortas From Hypertensive Rats
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., & Griendling, K. K. (1997) · Circulation Research · doi:10.1161/01.res.80.1.45 · Cited by 553
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
Wang, C.-H., Li, S.-H., Weisel, R. D., Fedak, P. W. M., Dumont, A. S., Szmitko, P., Li, R.-K., Mickle, D. A. G., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000061916.95736.e5 · Cited by 545
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Prognostic Significance of Small-Artery Structure in Hypertension
Rizzoni, D., Porteri, E., Boari, G. E. M., De Ciuceis, C., Sleiman, I., Muiesan, M. L., Castellano, M., Miclini, M., & Agabiti-Rosei, E. (2003) · Circulation · doi:10.1161/01.cir.0000095031.51492.c5 · Cited by 496
Intrinsic and extrinsic uncoupling of oxidative phosphorylation
Kadenbach, B. (2003) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(03)00027-6 · Cited by 486
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Horiuchi, M., Akishita, M., & Dzau, V. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.613 · Cited by 473
Intengan, H. D., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.312 · Cited by 459
Self-citationSpecificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling
Nathan, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18174 · Cited by 456
Pagano, P. J., Clark, J. K., Cifuentes-Pagano, M. E., Clark, S. M., Callis, G. M., & Quinn, M. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14483 · Cited by 455 · cited 1×
“ANG II increases production of reactive oxygen species in all types of vascular cells, including endothelial cells, smooth muscle cells, and adventitial fibroblasts (87, 90, 112).”
BackgroundUpregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid Injury
Szöcs, K., Lassègue, B., Sorescu, D., Hilenski, L. L., Valppu, L., Couse, T. L., Wilcox, J. N., Quinn, M. T., Lambeth, J. D., & Griendling, K. K. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.102189 · Cited by 444
Brush, J. E., Cannon, R. O., Schenke, W. H., Bonow, R. O., Leon, M. B., Maron, B. J., & Epstein, S. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192002 · Cited by 435
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Self-citationCoronary Endothelial Dysfunction in Humans Is Associated With Myocardial Perfusion Defects
Hasdai, D., Gibbons, R. J., Holmes, D. R., Higano, S. T., & Lerman, A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3390 · Cited by 398
Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms
Berk, B. C. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.999 · Cited by 383
The loss of endothelium-dependent vascular relaxation in hypertension.
Lockette, W., Otsuka, Y., & Carretero, O. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii61 · Cited by 372
Diep, Q. N., El Mabrouk, M., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345
Self-citationReactive oxygen species: Roles in blood pressure and kidney function
Wilcox, C. S. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0041-2 · Cited by 341
Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B.-Y., Tsao, P. S., Kimoto, M., Vallance, P., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340
Chiarugi, P., & Cirri, P. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00174-9 · Cited by 331
Growth Factors and Mitogen-Activated Protein Kinases
Force, T., & Bonventre, J. V. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.152 · Cited by 327
Park, J. B., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00013 · Cited by 325
Self-citationMolecular recognitions in the MAP kinase cascades
Tanoue, T., & Nishida, E. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00112-2 · Cited by 318
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Wright, J. T., Cushman, W. C., Davis, B. R., Barzilay, J., Colon, P., Egan, D., Lucente, T., Nwachuku, C., Pressel, S., Leenen, F. H. H., et al. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00176-3 · Cited by 311
Aalkjaer, C., Heagerty, A. M., Petersen, K. K., Swales, J. D., & Mulvany, M. J. (1987) · Circulation Research · doi:10.1161/01.res.61.2.181 · Cited by 308
Rocha, R., Martin-Berger, C. L., Yang, P., Scherrer, R., Delyani, J., & McMahon, E. (2002) · Endocrinology · doi:10.1210/en.2002-220120 · Cited by 308
Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II
Li, J.-M., & Shah, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209793200 · Cited by 307
v-SRC'S hold over actin and cell adhesions
Frame, M. C., Fincham, V. J., Carragher, N. O., & Wyke, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm779 · Cited by 305
Thybo, N. K., Stephens, N., Cooper, A., Aalkjaer, C., Heagerty, A. M., & Mulvany, M. J. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.474 · Cited by 299
Is C-reactive protein an independent risk factor for essential hypertension?
Bautista, L. E., López-Jaramillo, P., Vera, L. M., Casas, J. P., Otero, A. P., & Guaracao, A. I. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00004 · Cited by 299
Abnormalities of the Extracellular Degradation of Collagen Type I in Essential Hypertension
Laviades, C., Varo, N., Fernández, J., Mayor, G., Gil, M. J., Monreal, I., & Díez, J. (1998) · Circulation · doi:10.1161/01.cir.98.6.535 · Cited by 298
Different Mechanisms of Endothelial Dysfunction With Aging and Hypertension in Rat Aorta
Küng, C. F., & Lüscher, T. F. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.194 · Cited by 282
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
Tham, D. M., Martin-McNulty, B., Wang, Y.-X., Wilson, D. W., Vergona, R., Sullivan, M. E., Dole, W., & Rutledge, J. C. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2002 · Cited by 277
Touyz, R. M., Yao, G., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000069236.27911.68 · Cited by 270
Self-citationSchiffrin, E. L., Deng, L. Y., & Larochelle, P. (1994) · Hypertension · doi:10.1161/01.hyp.23.1.83 · Cited by 264
Self-citationTouyz, R. M., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200107000-00009 · Cited by 257
Self-citationOxidative stress and vascular damage in hypertension
Touyz, R. M. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0066-3 · Cited by 245
Self-citationTschudi, M. R., Mesaros, S., Lüscher, T. F., & Malinski, T. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.32 · Cited by 241
Vascular Hypertrophy and Remodeling in Secondary Hypertension
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Muiesan, P., Giulini, S. M., & Agabiti-Rosei, E. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.785 · Cited by 238
PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation
Diep, Q. N., Amiri, F., Touyz, R. M., Cohn, J. S., Endemann, D., Neves, M. F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000037969.41360.cc · Cited by 236
Self-citationRepair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease
Schwartzkopff, B., Brehm, M., Mundhenke, M., & Strauer, B. E. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.220 · Cited by 236
Intengan, H. D., Thibault, G., Li, J.-S., & Schiffrin, E. L. (1999) · Circulation · doi:10.1161/01.cir.100.22.2267 · Cited by 217
Self-citationTwisting integrin receptors increases endothelin-1 gene expression in endothelial cells
Chen, J., Fabry, B., Schiffrin, E. L., & Wang, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1475 · Cited by 200
Self-citationMechanics and Composition of Human Subcutaneous Resistance Arteries in Essential Hypertension
Intengan, H. D., Deng, L. Y., Li, J. S., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.569 · Cited by 199
Self-citationRole of Endothelin-1 in Hypertension
Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.876 · Cited by 195
Self-citationSchiffrin, E. L. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii1-a · Cited by 192
Self-citationSchiffrin, E. L., & Deng, L.-Y. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.699 · Cited by 192
Self-citationMulvany, M. J., Baandrup, U., & Gundersen, H. J. (1985) · Circulation Research · doi:10.1161/01.res.57.5.794 · Cited by 188
Rizzoni, D., Palombo, C., Porteri, E., Muiesan, M. L., Kozàkovà, M., La Canna, G., Nardi, M., Guelfi, D., Salvetti, M., Morizzo, C., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200303000-00030 · Cited by 187
Angiotensin II as a pro-inflammatory mediator.
Phillips, M. I., & Kagiyama, S. (2002) · PubMed · Cited by 183
Iglarz, M., Touyz, R. M., Amiri, F., Lavoie, M.-F., Diep, Q. N., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000047447.67827.cd · Cited by 183
Self-citationSchiffrin, E. L., & Deng, L. Y. (1996) · Journal of Hypertension · doi:10.1097/00004872-199610000-00014 · Cited by 182
Self-citationDiederich, D., Yang, Z. H., Buhler, F. R., & Luscher, T. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.258.2.h445 · Cited by 181
Lévy, B. I. (2004) · Circulation · doi:10.1161/01.cir.0000096609.73772.c5 · Cited by 176
Improvement of Coronary Flow Reserve After Long-term Therapy With Enalapril
Motz, W., & Strauer, B. E. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1031 · Cited by 175
Histology of subcutaneous small arteries from patients with essential hypertension.
Korsgaard, N., Aalkjaer, C., Heagerty, A. M., Izzard, A. S., & Mulvany, M. J. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.523 · Cited by 174
Suematsu, M., Suzuki, H., DeLano, F. A., & Schmid‐Schönbein, G. W. (2002) · Microcirculation · doi:10.1038/sj.mn.7800141 · Cited by 171
Navalkar, S., Parthasarathy, S., Santanam, N., & Khan, B. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01138-4 · Cited by 171
Transactivation: a Novel Signaling Pathway from Angiotensin II to Tyrosine Kinase Receptors
Saito, Y., & Berk, B. C. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1272 · Cited by 171
Diep, Q. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.004 · Cited by 165 · cited 1×
“Recently, it has been demonstrated that the activators of nuclear receptors, such as the peroxisome proliferator-activated receptors (PPARs), that are well-known hypolipidemic agents (the fibrates, PPAR -agonists), or insulin sensitizers (glitazones, PPAR- agonists), downregulate the cardiac (37) and vascular inflamma…”
BackgroundYoon, S.-O., Park, S.-J., Yoon, S. Y., Yun, C.-H., & Chung, A.-S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202647200 · Cited by 165
Ammarguellat, F., Gannon, P. O., Amiri, F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/hy0202.103481 · Cited by 163
Self-citationSignal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase
Eguchi, S., & Inagami, T. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00126-9 · Cited by 157
Inward Remodeling Follows Chronic Vasoconstriction in Isolated Resistance Arteries
Bakker, E. N. T. P., van der Meulen, E. T., van den Berg, B. M., Everts, V. E., Spaan, J. A. E., & VanBavel, E. (2002) · Journal of Vascular Research · doi:10.1159/000048989 · Cited by 154
Dang, P. M., Cross, A. R., Quinn, M. T., & BABIOR, B. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072345299 · Cited by 149
Correlation of endothelial function in large and small arteries in human essential hypertension.
Park, J. B., Charbonneau, F., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00009 · Cited by 147
Self-citationCostanzo, A., Moretti, F., BURGIO, V. L., Bravi, C., Guido, F., Levrero, M., & Puri, P. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10191 · Cited by 144
Xi, X.-P., Graf, K., Goetze, S., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.73 · Cited by 144
Schiffrin, E. L., Deng, L.-Y., & Larochelle, P. M. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)96211-2 · Cited by 142
Self-citationInflammation influences vascular remodeling through AT2receptor expression and signaling
Akishita, M., Horiuchi, M., Yamada, H., Zhang, L., Shirakami, G., Tamura, K., Ouchi, Y., & Dzau, V. J. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.2.1.13 · Cited by 142
Engström, G., Janzon, L., Berglund, G. L., Lind, P., Stavenow, L., Hedblad, B., & Lindgärde, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000041842.43905.f3 · Cited by 136
Schiffrin, E. L., Park, J. B., & Pu, Q. (2002) · Journal of Hypertension · doi:10.1097/00004872-200201000-00011 · Cited by 133
Self-citationFrank, G. D., Eguchi, S., Yamakawa, T., Tanaka, S., Inagami, T., & Motley, E. D. (2000) · Endocrinology · doi:10.1210/endo.141.9.7630 · Cited by 133
A Critical Review of the Role of Endothelial Factors in the Pathogenesis of Hypertension
Schiffrin, E. L. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111002-00002 · Cited by 133
Self-citationSuzuki, J., Iwai, M., Nakagami, H., Wu, L., Chen, R., Sugaya, T., Hamada, M., Hiwada, K., & Horiuchi, M. (2002) · Circulation · doi:10.1161/01.cir.0000024103.04821.86 · Cited by 133
Tadlock, L., Yamagiwa, Y., Hawker, J. R., Marienfeld, C. B., & Patel, T. C. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00550.2002 · Cited by 131
p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle
Meloche, S., Landry, J., Huot, J., Houle, F., Marceau, F., & Giasson, E. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h741 · Cited by 129
Touyz, R. M., He, G., Deng, L.-Y., & Schiffrin, E. L. (1999) · Circulation · doi:10.1161/01.cir.99.3.392 · Cited by 128
Self-citationTouyz, R. M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., & Schiffrin, E. L. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-164 · Cited by 128
Self-citationLacidipine Restores Endothelium-Dependent Vasodilation in Essential Hypertensive Patients
Taddei, S., Virdis, A., Ghiadoni, L., Uleri, S., Magagna, A., & Salvetti, A. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1606 · Cited by 121
Touyz, R. M., He, G., Wu, X., Park, J. B., Mabrouk, M. E., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.56 · Cited by 119
Self-citationPericellular plasmin induces smooth muscle cell anoikis
Meilhac, O., Ho‐Tin‐Noé, B., Houard, X., Philippe, M., Michel, J., & Anglés‐Cano, E. (2003) · The FASEB Journal · doi:10.1096/fj.02-0687fje · Cited by 117
Rizzoni, D., Muiesan, M. L., Porteri, E., Castellano, M., Zulli, R., Bettoni, G., Salvetti, M., Monteduro, C., & Agabiti‐Rosei, E. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715020-00011 · Cited by 116
Physiological and Pathophysiological Functions of the AT2Subtype Receptor of Angiotensin II
Henrion, D., Kubis, N., & Levy, B. I. (2001) · Hypertension · doi:10.1161/hy1101.096109 · Cited by 115
Moreno, M. U., José, G. S., Orbe, J., Páramo, J. A., Beloqui, Ó., Díez, J., & Zalba, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00331-4 · Cited by 112
Progression of chronic renal disease
Klahr, S., & Morrissey, J. J. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50074 · Cited by 111
Angiotensin and its AT2 receptor: new insights into an old system
Stoll, M., & Unger, T. A. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00246-4 · Cited by 110
Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension
Dohi, Y., Ohashi, M., Sugiyama, M., Takase, H., Sato, K., & Ueda, R. (2003) · Hypertension Research · doi:10.1291/hypres.26.691 · Cited by 106
Relations between cardiac and vascular structure in patients with primary and secondary hypertension
Rizzoni, D., Muiesan, M. L., Porteri, E., Salvetti, M., Castellano, M., Bettoni, G., Tiberio, G. A. M., Giulini, S. M., Monteduro, C., Garavelli, G., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00322-2 · Cited by 106
Angiotensin II Induces Catecholamine Release by Direct Ganglionic Excitation
Dendorfer, A., Thornagel, A., Raasch, W., Grisk, O., Tempel, K., & Dominiak, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000028001.65341.aa · Cited by 106
Touyz, R. M., Wu, X., He, G., Park, J. B., Chen, X., Vacher, J., Rajapurohitam, V., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200103000-00012 · Cited by 104
Self-citationCellular Hypertrophy in Subcutaneous Small Arteries of Patients With Renovascular Hypertension
Rizzoni, D., Porteri, E., Guefi, D., Piccoli, A., Castellano, M., Pasini, G., Muiesan, M. L., Mulvany, M. J., & Rosei, E. A. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.931 · Cited by 104
Li‐Saw‐Hee, F. L., Edmunds, E., Blann, A. D., et al. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(00)00274-6 · Cited by 99
Insulin Sensitivity and the Risk of Incident Hypertension
Goff, D. C., Zaccaro, D. J., Haffner, S. M., & Saad, M. F. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.805 · Cited by 99
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system?
van Heerebeek, L., Meischl, C., Stooker, W., Meijer, C. J. L. M., Niessen, H. W. M., & Roos, D. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.8.561 · Cited by 98
Haendeler, J., Yin, G., Hojo, Y., Saito, Y., Melaragno, M. G., Chen, Y., Sharma, V. K., Heller, M., Aebersold, R. H., & Berk, B. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307317200 · Cited by 97
Localization of vascular resistance changes during hypertension.
Bohlen, H. G. (1986) · Hypertension · doi:10.1161/01.hyp.8.3.181 · Cited by 96
Deng, L.-Y., Li, J., & Schiffrin, E. L. (1995) · Clinical Science · doi:10.1042/cs0880611 · Cited by 96
Self-citationSharifi, A. M., & Schiffrin, E. L. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00120-4 · Cited by 95
Self-citationIn Vivo Study of AT1and AT2Angiotensin Receptors in Apoptosis in Rat Blood Vessels
Diep, Q. N., Li, J., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.617 · Cited by 95
Self-citationTea, B.-S., Sarkissian, S. D., Touyz, R. M., Hamet, P., & deBlois, D. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1069 · Cited by 95
Self-citationMukai, Y., Shimokawa, H., Higashi, M., Morikawa, K., Matoba, T., Hiroki, J., Kunihiro, I., Hassan, T. M. A., & Takeshita, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029121.63691.ce · Cited by 94
Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications
Carey, R. M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02076-3 · Cited by 94
Touyz, R. M., He, G., Mabrouk, M. E., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.574 · Cited by 94
Self-citationFolkow, B. R. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00007 · Cited by 90
Apoptosis Occurs in Endothelial Cells during Hypertension-Induced Microvascular Rarefaction
Gobe, G. C., Browning, J., Howard, T., Hogg, N., Winterford, C. M., & Cross, R. B. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1996.3835 · Cited by 89
Muiesan, M. L., Rizzoni, D., Salvetti, M., Porteri, E., Monteduro, C., Guelfi, D., Castellano, M., Garavelli, G., & Agabiti‐Rosei, E. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00032 · Cited by 88
Schiffrin, E. L., Pu, Q., & Park, J. B. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02290-7 · Cited by 85
Self-citationSchiffrin, E. L., Deng, L.-Y., & Larochelle, P. M. (1993) · PubMed · Cited by 83
Self-citationRhoA/Rho-kinase, vascular changes, and hypertension
Chitaley, K., Weber, D. S., & Webb, R. C. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0028-4 · Cited by 82
Inflammation, the endothelium, and the acute coronary syndromes.
Kinlay, S., Selwyn, A. P., Libby, P., & Ganz, P. (1998) · PubMed · Cited by 74
Angiotensin II-mediated signal transduction pathways
Saito, Y., & Berk, B. C. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0042-1 · Cited by 73
Hlubocká, Z., Umnerová, V., Heller, S., Peleska, J., Jindra, A., Jáchymová, M., Kvasnička, J., Horký, K., & Aschermann, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001403 · Cited by 71
Rizzoni, D., Porteri, E., Giustina, A., Ciuceis, C. D., Sleiman, I., Boari, G. E. M., Castellano, M., Muiesan, M. L., Bonadonna, S., Burattin, A., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000114604.52270.95 · Cited by 70
O'Callaghan, C. J., & Williams, B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200202000-00019 · Cited by 67
Importance of Tyrosine Phosphorylation in Angiotensin II Type 1 Receptor Signaling
Schieffer, B., Paxton, W. G., Marrero, M. B., & Bernstein, K. E. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.476 · Cited by 67
Amann, K., Gharehbaghi, H., Stephan, S., & Mall, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.124 · Cited by 63
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo
Castoldi, G., Gioia, C. R. T. D., Pieruzzi, F., D’Orlando, C., van de Greef, W. M. M., Busca, G. A., Sperti, G., & Stella, A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2001 · Cited by 58
Simon, G., Íllyés, G., & Csiky, B. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.654 · Cited by 55
Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB
Tian, B., Liu, J., Bitterman, P. B., & Bache, R. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01139.2002 · Cited by 54
Meeting the challenges of the new K/DOQI guidelines
Eknoyan, G. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00371-8 · Cited by 44
Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats
Rizzoni, D., Rodella, L. F., Porteri, E., Rezzani, R., Guelfi, D., Piccoli, A., Castellano, M., Muiesan, M. L., Bianchi, R., & Rosei, E. A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018070-00010 · Cited by 43
Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans
Porteri, E., Rizzoni, D., Mulvany, M. J., Ciuceis, C. D., Sleiman, I., Boari, G. E. M., Castellano, M., Muiesan, M. L., Zani, F., & Rosei, E. A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200312000-00024 · Cited by 40
López-Farré, A. J., Rodríguez-Feo, J. A., García-Colis, E., Rivas, J. G., López-Blaya, A., Fortes, J., de Andrés, R., Rico, L., & Casado, S. (2002) · Journal of Hypertension · doi:10.1097/00004872-200203000-00022 · Cited by 40
Kamimura, M., Katus, H. A., Kreuzer, J., Teupser, D., Viedt, C., Fei, J., Krieger‐Brauer, H. I., & Brandes, R. P. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0500-5 · Cited by 37
Nelson, M. R., Reid, C., Krum, H., & McNeil, J. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01246-2 · Cited by 36
Hu, W., Fukuda, N., & Kanmatsuse, K. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00019 · Cited by 35
Wright, C. E., & Angus, J. A. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917120-00005 · Cited by 34
Eicosapentaenoic Acid Protects Endothelial Cells Against Anoikis Through Restoration of cFLIP
Suzuki, T., Fukuo, K., Suhara, T., Yasuda, O., Sato, N., Takemura, Y., Tsubakimoto, M., & Ogihara, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000084602.06114.ad · Cited by 33
Maturana, A. D., Krause, K., & Demaurex, N. (2002) · The Journal of General Physiology · doi:10.1085/jgp.20028713 · Cited by 33
Wilkie, N., Ng, L. L., & Boarder, M. R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701366 · Cited by 32
Murakawa, Y., Yamashita, T., Ajiki, K., Sezaki, K., & Omata, M. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199807000-00010 · Cited by 32
Sihm, I., Schroeder, A. P., Aalkjaer, C., Mulvany, M. J., Thygesen, K., & Lederballe, O. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00475-5 · Cited by 31
Izzard, A. S., Bund, S. J., & Heagerty, A. M. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.604 · Cited by 27
Apoptosis in the muscular arteries from young spontaneously hypertensive rats
Dickhout, J. G., & Lee, R. M. K. W. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917100-00008 · Cited by 27
Wright, C. E., Angus, J. A., & Korner, P. I. (2002) · Journal of Hypertension · doi:10.1097/00004872-200203000-00023 · Cited by 27
Vega, F. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00045-x · Cited by 23
Delva, P., Lechi, A., Pastori, C., Degan, M., Sheiban, I., Montesi, G., Pea, M., Meneguzzi, A., & Menegazzi, M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00026 · Cited by 21
Apoptosis in Cardiovascular Remodeling—Effect of Medication
deBlois, D., Orlov, S. N., & Hamet, P. (2001) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1013723922582 · Cited by 19
Sepiapterin Decreases Vasorelaxation in Nitric Oxide Synthase Inhibition–Induced Hypertension
Mitchell, B. M., Dorrance, A. M., Ergul, A., & Webb, R. C. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200401000-00014 · Cited by 19
Cloning, Expression and Regulation of Angiotensin II Receptors
Inagami, T., Yamano, Y., Bardhan, S., Chaki, S., Guo, D., Ohyama, K., Kambayashi, Y., Takahashi, K., Ichiki, T., Tsuzuki, S., et al. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0952-7_21 · Cited by 19
Structure and the resistance amplifier in hypertension
Korner, P. I., Angus, J. A., & Wright, C. E. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018020-00016 · Cited by 16
Interactions Between NO and cAMP in the Regulation of Vascular Tone
Lamping, K. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.729 · Cited by 13
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Self-citationVascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease
Lacolley, P., Regnault, V., Segers, P., & Laurent, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00003.2017 · Cited by 734
Redox signaling in hypertension
PARAVICINI, T., & TOUYZ, R. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.001 · Cited by 577
Self-citationHypertension and Cerebrovascular Dysfunction
Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Metadata
- Authors
- Schiffrin, E. L., & Touyz, R. M.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2004-08
- Volume
- 287
- Issue
- 2
- Pages
- H435-H446
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2157057477
- Cited by
- 253
- References
- 187
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.